• Featured Product
  • KD/KO Validated

EZH2 Monoklonaler Antikörper

EZH2 Monoklonal Antikörper für FC, WB, ELISA

Wirt / Isotyp

Maus / IgG1

Getestete Reaktivität

human, Maus, Ratte

Anwendung

WB, IP, IHC, IF, FC, ELISA

Konjugation

Unkonjugiert

CloneNo.

1F10A12

Kat-Nr. : 66476-1-Ig

Synonyme

Enhancer of zeste homolog 2, ENX 1, ENX-1, EZH1, EZH2, KMT6, Lysine N methyltransferase 6



Geprüfte Anwendungen

Erfolgreiche Detektion in WBHEK-293-Zellen, 4T1-Zellen, A431-Zellen, A549-Zellen, Jurkat-Zellen, NIH/3T3-Zellen, PC-3-Zellen, ROS1728-Zellen
Erfolgreiche Detektion in FCHepG2-Zellen

Empfohlene Verdünnung

AnwendungVerdünnung
Western Blot (WB)WB : 1:5000-1:20000
Durchflusszytometrie (FC)FC : 0.20 ug per 10^6 cells in a 100 µl suspension
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Produktinformation

66476-1-Ig bindet in WB, IP, IHC, IF, FC, ELISA EZH2 und zeigt Reaktivität mit human, Maus, Ratten

Getestete Reaktivität human, Maus, Ratte
In Publikationen genannte Reaktivitäthuman, Maus
Wirt / Isotyp Maus / IgG1
Klonalität Monoklonal
Typ Antikörper
Immunogen EZH2 fusion protein Ag16789
Vollständiger Name enhancer of zeste homolog 2 (Drosophila)
Berechnetes Molekulargewicht 751 aa, 86 kDa
Beobachtetes Molekulargewicht 90-102 kDa
GenBank-ZugangsnummerBC010858
Gene symbol EZH2
Gene ID (NCBI) 2146
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3.
LagerungsbedingungenBei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

EZH2 (enhancer of zeste homologue 2, also known as KMT6) is a member of Polycomb group (PcG) family and encodes a histone methyl transferase that has an essential role in promoting histone H3 lysine 27 trimethylation (H3K27me3) and epigenetic gene silencing. EZH2 is important for cell proliferation and inhibition of cell differentiation, and is implicated in cancer progression. Overexpression of EZH2 is a marker of advanced and metastatic disease in many solid tumors, including prostate and breast cancer. This antibody detected EZH2 protein as a single band with a molecular weight (MW) of 91-100 kDa in multiple cell lines. The phosphorylation may result in the higher molecular weight (calculated MW as 80-86 kDa). (20935635, 21367748)

Protokolle

Produktspezifische Protokolle
WB protocol for EZH2 antibody 66476-1-IgProtokoll herunterladen
FC protocol for EZH2 antibody 66476-1-IgProtokoll herunterladen
Standard-Protokolle
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen

Publikationen

SpeciesApplicationTitle
humanWB

Cell Death Dis

Long noncoding RNA MEG3 regulates LATS2 by promoting the ubiquitination of EZH2 and inhibits proliferation and invasion in gallbladder cancer.

Authors - Longyang Jin
humanWB,IHC

Front Cell Dev Biol

Exosome-Delivered LncHEIH Promotes Gastric Cancer Progression by Upregulating EZH2 and Stimulating Methylation of the GSDME Promoter.

Authors - Yan Lu
  • KD Validated
mouseWB

Front Cell Dev Biol

Emerin interacts with histone methyltransferases to regulate repressive chromatin at the nuclear periphery

Authors - Nicholas Marano
humanWB

Cancer Med

LncRNA SPRY4-IT1 facilitates cell proliferation and angiogenesis of glioma via the miR-101-3p/EZH2/VEGFA signaling axis

Authors - Ji Wang
mouseWB,IP

Int Immunopharmacol

Celastrol attenuates diabetic nephropathy by upregulating SIRT1-mediated inhibition of EZH2related wnt/β-catenin signaling

Authors - Yuewen Tang
IF

Bioact Mater

Engineered mesenchymal stem cell-derived small extracellular vesicles for diabetic retinopathy therapy through HIF-1α/EZH2/PGC-1α pathway

Authors - Fengtian Sun